SeekingAlphaSeptember 22, 2026 at 6:14 AM NYLast Month
Medtronic: Don't Miss Out On This Dividend Aristocrat Deal Now
Medtronic is rated a Buy, citing Q1 2027 beat, raised FY2027 EPS guidance, solid debt metrics, and 15% undervalued. Read the latest analysis on MDT stock here.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
